Advertisement

Chromatographia

, Volume 67, Issue 3–4, pp 293–297 | Cite as

Simultaneous Determination of Seven Bioactive Compounds in Chinese Medicine “QI-SHEN-YI-QI” Dropping Pill by LC-UV and LC-ELSD

Full Short Communication

Abstract

A high performance liquid chromatography coupled with ultraviolet detection and evaporative light scattering detection (HPLC-UV-ELSD) method was developed for simultaneously determining seven bioactive components, i.e. danshensu, protocatechuic aldehyde, salvianolic acid B, notoginsenoside R1, ginsenoside Rg1, ginsenoside Rb1, and astragaloside IV in “QI-SHEN-YI-QI” dropping pill, a widely used traditional Chinese medicine (TCM) for treating cardiovascular disease. The chromatographic separation was performed on a Zorbax Stable Bond C18 column using gradient elution with acetonitrile and water with acceptable validation results such as linearity and recovery. The recoveries of the seven investigated compounds ranged from 93.3 to 100.2% with RSD values less than 5%. More importantly, this proposed method was successfully used to determine the seven compounds in nine batches of “QI-SHEN-YI-QI” dropping pills, which indicated that the proposed method could be readily utilized as a quality control method for this TCM preparation.

Keywords

Column liquid chromatography Evaporative light scattering detection Quantitative analysis Traditional Chinese medicine “QI-SHEN-YI-QI” dropping pill 

Notes

Acknowledgments

This work was financially supported by the China State Key Basic Research Program Grant (2005CB523402) and by Program for New Century Excellent Talents in University (NCET-06-0515). We thank TASLY Pharmaceutical Co Ltd (Tianjin, China) for kindly providing us commercial products of “QI-SHEN-YI-QI” dropping pills.

References

  1. 1.
    Zhou Z, Liu Y, Miao AD, Wang SQ (2005) Eur J Pharmacol 513:1–8CrossRefGoogle Scholar
  2. 2.
    Shi CS, Huang HC, Wu HL, Kuo CH, Chang BI, Shiao M, Shi GY (2007) Thromb Res 119:769–775CrossRefGoogle Scholar
  3. 3.
    Zhang HS, Wang SQ (2006) Vasc Pharmacol 44:224–230CrossRefGoogle Scholar
  4. 4.
    Leung KW, Pon YL, Wong RNS, Wong AST (2006) J Biol Chem 281:36280–36288CrossRefGoogle Scholar
  5. 5.
    Zhou W, Chai H, Lin PH, Lumsden AB, Yao QZ, Chen CY (2005) J Vasc Surg 41:861–868CrossRefGoogle Scholar
  6. 6.
    Zhang BQ, Hu SJ, Qiu LH, Zhu JH, Xie XJ, Sun J, Zhu ZH, Xia Q, Bian K (2007) Vasc Pharmacol 46:278–285CrossRefGoogle Scholar
  7. 7.
    Kwan CY, Kwan TK (2000) Acta Pharmacol Sin 21:1101–1105Google Scholar
  8. 8.
    Sun HX, Ye YP, Pan HJ, Pan YJ (2004) Vaccine 22:3882–3889CrossRefGoogle Scholar
  9. 9.
    Wei YJ, Li SL, Li P (2007) Biomed Chromatogr 21:1–9CrossRefGoogle Scholar
  10. 10.
    Oleszek WA (2002) J Chromatogr A 967:147–162CrossRefGoogle Scholar
  11. 11.
    Xing J, Xie CF, Lou HX (2007) J Pharm Biomed 44:368–378CrossRefGoogle Scholar
  12. 12.
    Xu MJ, Wang GJ, Xie HT, Wang R, Wang W, Li XY, Sun JG (2006) Anal Lett 39:113–126CrossRefGoogle Scholar
  13. 13.
    Yan LX, Guo DA (2005) J Chromatogr B 824:244–248CrossRefGoogle Scholar
  14. 14.
    Ji HY, Lee HW, Kim HK, Kim HH, Chang SG, Sohn DH, Kim J, Lee HS (2004) J Pharm Biomed 35:207–212CrossRefGoogle Scholar
  15. 15.
    Chai XY, Li SL, Li P (2005) J Chromatogr A 1070:43–48CrossRefGoogle Scholar
  16. 16.
    Li WK, Fitzloff JF (2001) J Pharm Pharmacol 53:1637–1643CrossRefGoogle Scholar
  17. 17.
    Oleszek W, Bialy Z (2006) J Chromatogr A 1112:78–91CrossRefGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlag/GWV Fachverlage GmbH 2008

Authors and Affiliations

  1. 1.Department of Chinese Medicine Science and EngineeringZhejiang UniversityHangzhouPeople’s Republic of China

Personalised recommendations